Penicillin's β-lactam ring breaks down within hours when exposed to moisture, acid, or heat, making purification the real challenge after Fleming's discovery
Ernst Chain solved it with pH-dependent solvent extraction; Norman Heatley scaled it with improvised equipment including bedpans and urine recycling
Albert Alexander, the first patient treated, died not because the drug failed but because there was not enough of it
A Peoria cantaloupe yielded the high-producing strain that made mass production possible; corn steep liquor increased yields by over 1,000%
The same β-lactam ring vulnerability that plagued 1939 purification is the mechanism bacteria exploit for antibiotic resistance today
Penicillin nearly failed, not because it could not kill bacteria, but because scientists could not keep it alive long enough to use it.
The same β-lactam ring that makes penicillin deadly to bacteria is also chemically fragile. Moisture, heat, acid, and metal ions can destroy it within hours. After Alexander Fleming discovered penicillin in 1928, researchers spent more than a decade trying to stop the drug from falling apart before patients could receive it.
Every attempt to concentrate or store penicillin in the 1920s and 1930s ended in the drug losing its antibacterial activity. Fleming concluded, reasonably at the time, that it was too unstable for clinical use. Fleming lacked both the biochemical tools and industrial support needed to isolate penicillin in a stable form. At the time, neither freeze-drying technology nor large-scale fermentation methods were advanced enough to preserve the compound reliably.
The β-lactam ring is chemically unstable because its four-membered structure is highly strained, making it unusually susceptible to rupture by water or enzymes.
The breakthrough came in 1939, when biochemist Ernst Chain at Oxford's Sir William Dunn School of Pathology recognised that instability was a purification hurdle, and not a chemical dead end. He introduced pH-dependent solvent extraction: at acid pH, penicillin becomes hydrophobic enough to move from the broth into organic solvents such as ethyl acetate. By quickly shifting the extract back into a neutral aqueous buffer, he recovered a partially purified, concentrated solution before the ring had time to hydrolyse. This was a crude approach, but it worked.
It was Norman Heatley, however, who scaled this laboratory insight into a functional production line. Lacking standard equipment, he improvised by using ceramic hospital vessels, biscuit tins, and bedpans as shallow trays to grow enough Penicillium notatum broth for clinical trials. When pharmaceutical-grade freeze-dryers became available, Heatley and pharmacist Gordon Sanders used lyophilisation (freezing the extract and removing moisture under a vacuum), to produce a stable, storable powder for the first time.
There was no doubt about the temporary clinical improvement, and, most importantly, there had been no sort of toxic effect during the five days of continuous administration of penicillin.Dr. Charles Fletcher, Physician who administered penicillin to Albert Alexander, British Medical Journal, 1984
On 12 February 1941, a 43-year-old Oxford police constable named Albert Alexander became the first human to receive penicillin therapy. He had developed a life-threatening, mixed bacterial sepsis; his face was grossly abscessed and one eye was already lost. Within 24 hours of his first injection, his fever reduced and the infection began to visibly retreat.
The Oxford team had so little penicillin, that they were forced to extract the it from Alexander's urine, as roughly 80% of a dose is excreted unchanged, and re-injected it to stretch the supply. After five days of injections recycled from his own urine, the supply was finally exhausted.
Alexander had been showing improvement for over a week, but without enough drug to finish the treatment, he relapsed and died on 15 March 1941. Not because the drug was ineffective, but because there was not enough supply, highlighting that laboratory success alone could not make a therapy clinically viable.
With wartime Britain lacking both industrial capacity and resources for pharmaceutical scale-up, Florey and Heatley made the decision to cross the Atlantic. In the summer of 1941, Howard Florey and Heatley crossed the Atlantic to the US Department of Agriculture's Northern Regional Research Laboratory in Peoria, Illinois. What happened there transformed penicillin from a laboratory rarity into an industrial product in under two years.
NRRL microbiologist Andrew Moyer discovered that replacing standard growth medium with corn steep liquor (a thick, nitrogen-rich by-product of cornstarch production), essentially industrial waste, boosted penicillin yields by over 1,000 percent. This was because Penicillium produces penicillin as a secondary metabolite under nitrogen stress, whereas corn steep liquor appeared to provide an ideal nutritional environment to trigger peak output.
A global quest for higher-yielding mould strains culminated in 1943 when a rotting melon from a Peoria grocery store yielded Penicillium chrysogenum (NRRL 1951), a strain producing over 200 times the penicillin of Fleming's original. UV mutagenesis of this strain pushed yields even further.
Simultaneously, Pfizer's Brooklyn facility, adapting its existing citric acid fermentation infrastructure, opened the first commercial deep-tank penicillin line in March 1944.
By D-Day, June 1944, the Allies had stockpiled enough penicillin for the Normandy campaign. Wartime US production reached 650 billion units per month by mid-1945. The price per dose had fallen from $20 to under $1.
In 1945, Dorothy Crowfoot Hodgkin used X-ray crystallography to confirm penicillin's β-lactam structure, laying the groundwork for later generations of semisynthetic antibiotics.
However, the molecule's central instability that had nearly defeated purification in 1939 remained. Bacteria evolved β-lactamase enzymes that cleave the β-lactam ring by precisely the same hydrolysis chemistry that plagued every early purification attempt.
Modern challenges, including Methicillin-Resistant Staphylococcus aureus (MRSA), carbapenem-resistant organisms, and the broader antibiotic resistance crisis all trace back to bacteria exploiting the structural liability of β-lactams. Modern antibiotic combinations such as amoxicillin-clavulanate attempt to overcome this problem by pairing β-lactam antibiotics with β-lactamase inhibitors that protect the ring from enzymatic destruction.
The scientists who solved wartime purification could not have known they were also describing, in outline, the molecular basis of the resistance crisis that would follow. The bedpan fermenters and urine-recycling circuits of 1941 Oxford were, in a real sense, the first encounter with the same enemy; the ring's chemical fragility.
In India, all penicillin-class antibiotics are Schedule H drugs under the Drugs and Cosmetics Act, 1940, meaning they require a valid prescription from a registered medical practitioner and cannot be dispensed over the counter. The National Action Plan on Antimicrobial Resistance (NAP-AMR), coordinated under ICMR and MoHFW, explicitly identifies inappropriate antibiotic dispensing as a primary AMR driver in India. The link between penicillin's biochemical history and India's current resistance burden is direct and clinically relevant.
Penicillin's antibacterial activity depends on its β-lactam ring, a chemically strained four-membered structure that rapidly hydrolyses (breaks apart) when exposed to water, acid, heat, or metal ions. Every early concentration attempt destroyed the ring before enough drug could be collected. Solving this required pH-dependent solvent extraction at cold temperatures, followed by freeze-drying to produce a stable powder.
While Fleming discovered the antibacterial effect in 1928, it was Howard Florey, Ernst Chain, and, critically, Norman Heatley at Oxford who developed purification and scale-up methods between 1939 and 1941. The industrial breakthrough came at the NRRL in Peoria, USA, where Andrew Moyer introduced corn steep liquor as a culture medium, increasing yields over 1,000 percent.
Albert Alexander, a 43-year-old Oxford police constable, was injected with penicillin on 12 February 1941. He began recovering dramatically within 24 hours. However, the Oxford team had so little drug that they recycled penicillin from his urine. Stocks ran out by day 5; Alexander relapsed and died on 15 March 1941. He was not the first patient cured, that distinction belongs to Anne Miller in the US in March 1942.
Corn steep liquor is a viscous by-product of cornstarch wet-milling, rich in nitrogen, amino acids, and growth factors. It was essentially industrial waste before the Peoria team discovered that it triggered Penicillium to massively upregulate penicillin production as a secondary metabolite, increasing yields by over 1,000 percent. It became the economic foundation of industrial antibiotic manufacturing.
The same chemistry that made early purification so difficult, the vulnerability of the β-lactam ring to hydrolysis, is what bacteria exploit for antibiotic resistance. β-lactamase enzymes evolved by bacteria cleave the β-lactam ring by nucleophilic hydrolysis, the same reaction that destroyed penicillin in early lab extracts. MRSA and carbapenem-resistant organisms all exploit variants of this mechanism.
1. Chain E, Florey HW, Gardner AD, et al. Penicillin as a chemotherapeutic agent. Lancet. 1940;236(6104):226–228. https://doi.org/10.1016/S0140-6736(01)08728-1
2. Gaynes R. The discovery of penicillin — new insights after more than 75 years of clinical use. Emerg Infect Dis. 2017;23(5):849–853. https://pmc.ncbi.nlm.nih.gov/articles/PMC5403050/
3. Moyer AJ, Coghill RD. Penicillin VIII: Production of penicillin in surface cultures. J Bacteriol. 1946;51(1):57–78. https://pmc.ncbi.nlm.nih.gov/articles/PMC518023/
4. American Chemical Society. Development of Deep-tank Fermentation, Pfizer Inc. (National Historic Chemical Landmark). ACS; 2008. https://www.acs.org/content/dam/acsorg/education/whatischemistry/landmarks/penicillin/development-of-deep-tank-fermentation-commemorative-booklet.pdf
5. Fletcher C. First clinical use of penicillin. Br Med J (Clin Res Ed). 1984;289(6460):1721–1723. https://doi.org/10.1136/bmj.289.6460.1721
6. Lax E. The Mold in Dr. Florey's Coat: The Story of the Penicillin Miracle. New York: Henry Holt; 2004.
7. Kong KF, Schneper L, Mathee K. Beta-lactam antibiotics: From antibiosis to resistance and bacteriology. APMIS. 2010;118(1):1–36. https://doi.org/10.1111/j.1600-0463.2009.02563.x
8. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940;146:837. https://doi.org/10.1038/146837a0